DNA methylation markers in the detection of hepatocellular carcinoma
European Journal of Cancer · 2023-09 · 191 · 112960
DOI: 10.1016/j.ejca.2023.112960 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2023-09. Verfasst von Siyu Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and has a poor prognosis. Epigenetic modification has been shown to be deregulated during HCC development by dramatically impacting the differentiation, proliferation, and function of cells. One important epigenetic modification is DNA methylation during which methyl groups are added to cytosines without changing the DNA sequence itself. Studies found that methylated DNA markers can be specific for detection of HCC. On the basis of these findings, the utility of methylated DNA markers as novel biomarkers for early-stage HCC has been measured in blood, and indeed superior sensitivity and specificity have been found in several studies when compared to current surveillance methods. However, a variety of factors currently limit the immediate application of these exciting biomarkers. In this review, we provide a detailed rationalisation of the approach and basis for the use of methylation biomarkers for HCC detection and summarise recent studies on methylated DNA markers in HCC focusing on the importance of the aetiological cause of liver disease in the mechanisms leading to cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Erasmus MC University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands.
- Erasmus MC University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
- Erasmus MC University Medical Center, Department of Gastroenterology and Hepatology, Rotterdam, the Netherlands. Electronic address: p.a.boonstra@erasmusmc.nl.
Förderung
- FIC NIH HHS
Zitieren
APA
Fu, S., Debes, J. D., & Boonstra, A. (2023). DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer, 191, 112960. https://doi.org/10.1016/j.ejca.2023.112960
Vancouver
Fu S, Debes JD, Boonstra A. DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer. 2023;191:112960. doi:10.1016/j.ejca.2023.112960
BibTeX
@article{Fu2023,
author = {Fu, Siyu and Debes, José D and Boonstra, André},
title = {DNA methylation markers in the detection of hepatocellular carcinoma},
journal = {European Journal of Cancer},
year = {2023},
volume = {191},
pages = {112960},
doi = {10.1016/j.ejca.2023.112960}
}
EUVIMED